This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Maurice Van Allen, MD

JAMA. 1979;241(13):1391-1392.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Stroke: Its Prevention, Its Treatment

Stroke, risk factors for degenerative vascular disease, and transient ischemic attacks (TIAs) continue to be major preoccupations of those in neurology. The majority of TIAs seem to be due to forward embolism from atheromatous plaques in the major vessels. Endarterectomy, anticoagulant agents, and platelet antiaggregating drugs (aspirin, sulfinpyrazone, dipyridamole) are the available modalities for treatment after cardiac and hematologic disorders have been eliminated as causes for circulatory insufficiency. Millikan and McDowell¹ have provided an excellent review of the subject.

When angiography demonstrates an atheromatous plaque at the carotid bifurcation, many investigators prefer surgical treatment. Still, however, the risks of both angiography and surgery must be weighed, and we have as yet no consensus on the long-term advantages of surgical operation over medical treatment.^2,3 The frequency of TIAs can be reduced if anticoagulants such as heparin sodium and warfarin sodium are used early on, . . . [Full Text PDF of this Article]

Author Affiliations
Iowa City

From the Department of Neurology, University of Iowa Hospitals, Iowa City.

Footnotes
Member, editorial board, The Journal.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?